Upon RDC11 administration in human colorectal adenocarcinoma (HCT116 cell line) in vivo, levels of HIF-1α were significantly reduced and, consequently, VEGF levels and angiogenesis, leading to a reduction in tumor size [35]. This evidence concerns the gene HIF1A and neoplasm.